K. Nakagawa

发表

The longitudinal effect of the aldehyde dehydrogenase 2*2 allele on the risk for nonalcoholic fatty liver disease

K. Oniki, K. Morita, T. Watanabe, 2016, Nutrition & Diabetes.

Association between the aldehyde dehydrogenase 2*2 allele and smoking-related chronic airway obstruction in a Japanese general population: a pilot study.

K. Oniki, K. Morita, A. Kajiwara, 2015, Toxicology letters.

Combined effects of current-smoking and the aldehyde dehydrogenase 2*2 allele on the risk of myocardial infarction in Japanese patients.

S. Hokimoto, Y. Arima, H. Ogawa, 2015, Toxicology letters.

Aldehyde dehydrogenase 2 as a potential protective factor for renal insufficiency in Japanese subjects with heart failure: a pilot study

S. Hokimoto, H. Ogawa, K. Oniki, 2014, Journal of Human Hypertension.

Impact of CYP2C19 polymorphism on residual platelet reactivity in patients with coronary heart disease during antiplatelet therapy.

S. Hokimoto, K. Kaikita, K. Tsujita, 2011, Journal of cardiology.

Sex Differences in the Renal Function Decline of Patients with Type 2 Diabetes

K. Oniki, K. Morita, A. Kajiwara, 2016, Journal of diabetes research.

Interactive effects of smoking and glutathione S-transferase polymorphisms on the development of non-alcoholic fatty liver disease.

K. Oniki, K. Morita, A. Kajiwara, 2013, Toxicology letters.

Sex- and age-dependent gene expression in human liver: An implication for drug-metabolizing enzymes.

Yusuke Nakamura, T. Katagiri, H. Yamazaki, 2017, Drug metabolism and pharmacokinetics.

CD14 Gene Variants and Their Importance for Childhood Croup, Atopy, and Asthma

C. Karunanayake, A. Senthilselvan, J. Dosman, 2013, Disease markers.

Influence of the PNPLA3 rs738409 Polymorphism on Non-Alcoholic Fatty Liver Disease and Renal Function among Normal Weight Subjects

K. Oniki, K. Morita, A. Kajiwara, 2015, PloS one.

Superoxide scavenging activity of pirfenidone-iron complex.

Keizo Sato, K. Nakagawa, K. Sasamoto, 2008, Biochemical and biophysical research communications.

A population phenotyping study of three drug‐metabolizing enzymes in Kyushu, Japan, with use of the caffeine test

H. Yamazaki, T. Kamataki, T. Ishizaki, 2002, Clinical pharmacology and therapeutics.

Glutathione S-transferase K1 genotype and overweight status in schizophrenia patients: A pilot study

Norio Sugawara, N. Yasui-Furukori, K. Oniki, 2016, Psychiatry Research.

The in‐vivo effects of sho‐saiko‐to, a traditional Chinese herbal medicine, on two cytochrome P450 enzymes (1A2 and 3A) and xanthine oxidase in man

T. Ishizaki, K. Nakagawa, J. Saruwatari, 2003, The Journal of pharmacy and pharmacology.

Potential relationships between transaminase abnormality and valproic acid clearance or serum carnitine concentrations in Japanese epileptic patients

Y. Ando, K. Nakagawa, Shiro Nagata, 2008, The Journal of pharmacy and pharmacology.

Impact of esomeprazole on platelet reactivity and clinical outcome according to CYP2C19 genotype in coronary heart disease patients during dual antiplatelet therapy.

K. Sakamoto, N. Tabata, S. Hokimoto, 2015, Thrombosis research.

Comparison of the effect of CYP2C19 polymorphism on clinical outcome between acute coronary syndrome and stable angina.

S. Hokimoto, Y. Arima, K. Kaikita, 2015, Journal of cardiology.

Abstract 11886: Chronic Kidney Disease Status Modifies the Association of CYP2C19 Polymorphism in Predicting Clinical Outcomes Following Coronary Stent Implantation

N. Tabata, S. Hokimoto, Y. Arima, 2014 .

A functional variant in the γ-glutamyltransferase (GGT)1 gene is associated with airflow obstruction in smokers

K. Oniki, K. Morita, A. Kajiwara, 2015, Clinical chemistry and laboratory medicine.

Interactive effects of a common γ-glutamyltransferase 1 variant and low high-density lipoprotein-cholesterol on diabetic macro- and micro-angiopathy

S. Hokimoto, H. Ogawa, K. Oniki, 2015, Cardiovascular Diabetology.

Decreased coumarin 7-hydroxylase activities and CYP2A6 expression levels in humans caused by genetic polymorphism in CYP2A6 promoter region (CYP2A6*9).

H. Yamazaki, T. Shimada, F. Guengerich, 2003, Pharmacogenetics.

CYP2A6 IS A PRINCIPAL ENZYME INVOLVED IN HYDROXYLATION OF 1,7-DIMETHYLXANTHINE, A MAIN CAFFEINE METABOLITE, IN HUMANS

H. Yamazaki, K. Kiyotani, T. Kamataki, 2005, Drug Metabolism and Disposition.

Twenty one novel single nucleotide polymorphisms (SNPs) of the CYP2A6 gene in Japanese and Caucasians.

H. Yamazaki, T. Shimada, F. Guengerich, 2002, Drug metabolism and pharmacokinetics.

Determination of cut-off levels for on-clopidogrel platelet aggregation based on functional CYP2C19 gene variants in patients undergoing elective percutaneous coronary intervention.

S. Hokimoto, Koji Sato, S. Tayama, 2011, Thrombosis research.

Impact of CYP3A5 polymorphism on platelet reactivity at percutaneous coronary intervention and after 9 months of aspirin and clopidogrel therapy in Japanese patients with coronary artery disease

S. Hokimoto, Y. Arima, K. Kaikita, 2014, European Journal of Clinical Pharmacology.

ABCC2 rs2273697 and rs3740066 polymorphisms and resistance to antiepileptic drugs in Asia Pacific epilepsy cohorts.

H. Tan, P. Kwan, K. Lim, 2014, Pharmacogenomics.

Glutathione S-transferase A1 polymorphism as a risk factor for smoking-related type 2 diabetes among Japanese.

K. Oniki, K. Nakagawa, S. Mihara, 2008, Toxicology letters.

A preliminary investigation of the association between haptoglobin polymorphism, serum ferritin concentration and fatty liver disease.

K. Nakagawa, S. Mihara, M. Hori, 2008, Clinica chimica acta; international journal of clinical chemistry.

Effects of genotypic differences in CYP2C19 status on cure rates for Helicobacter pylori infection by dual therapy with rabeprazole plus amoxicillin.

H. Sugimura, K. Ohashi, T. Ishizaki, 2001, Pharmacogenetics.

Assessment of platelet‐derived thrombogenicity with the total thrombus‐formation analysis system in coronary artery disease patients receiving antiplatelet therapy

K. Sakamoto, M. Ishii, S. Hokimoto, 2016, Journal of thrombosis and haemostasis : JTH.

Gender Differences in Impact of CYP2C19 Polymorphism on Development of Coronary Artery Disease

N. Tabata, S. Hokimoto, Y. Arima, 2014, Journal of cardiovascular pharmacology.

Intraprocedural thrombotic event during coronary intervention depends on CYP2C19 genotype and is a predictor of future clinical event.

K. Sakamoto, N. Tabata, S. Hokimoto, 2015, International journal of cardiology.

Impact of CYP2C19 polymorphism and proton pump inhibitors on platelet reactivity to clopidogrel and clinical outcomes following stent implantation.

S. Hokimoto, Y. Arima, K. Kaikita, 2014, Thrombosis research.

Chronic kidney disease status modifies the association of CYP2C19 polymorphism in predicting clinical outcomes following coronary stent implantation.

N. Tabata, S. Hokimoto, Y. Arima, 2014, Thrombosis research.

Repetitive early stent thrombosis in a patient with the CYP2C19*3/*3 genotype.

S. Hokimoto, S. Takashio, K. Fujimoto, 2011, Journal of cardiology cases.

Association between combinations of glutathione‐S‐transferase M1, T1 and P1 genotypes and non‐alcoholic fatty liver disease

K. Oniki, K. Nakagawa, S. Mihara, 2009, Liver international : official journal of the International Association for the Study of the Liver.

Glutathione-S-transferase (GST) M1 null genotype and combined GSTM1 and GSTT1 null genotypes are risk factors for increased serum gamma-glutamyltransferase in valproic acid-treated patients.

K. Nakagawa, Takayuki Seo, T. Ishitsu, 2008, Clinica chimica acta; international journal of clinical chemistry.

Glutathione S-transferase M1 null genotype as a risk factor for carbamazepine-induced mild hepatotoxicity.

K. Nakagawa, M. Hori, Takayuki Seo, 2007, Pharmacogenomics.

Impact of CYP2D6*10 on H1-antihistamine-induced hypersomnia

T. Kamataki, K. Oniki, K. Nakagawa, 2006, European Journal of Clinical Pharmacology.

Risk Factors for Adverse Symptoms During Dipeptidyl Peptidase-IV Inhibitor Therapy: A Questionnaire-Based Study Carried Out by the Japan Pharmaceutical Association Drug Event Monitoring Project in Kumamoto Prefecture

K. Oniki, K. Morita, A. Kajiwara, 2013, Drug Safety.

CYP2C19 variants and epoxyeicosatrienoic acids in patients with microvascular angina

Y. Izumiya, N. Tabata, S. Hokimoto, 2017, International journal of cardiology. Heart & vasculature.

Association of CYP2C19 variants and epoxyeicosatrienoic acids on patients with microvascular angina.

Y. Izumiya, N. Tabata, S. Hokimoto, 2016, American journal of physiology. Heart and circulatory physiology.

Sex differences in the impact of CYP2C19 polymorphisms and low-grade inflammation on coronary microvascular disorder.

K. Sakamoto, N. Tabata, S. Hokimoto, 2016, American journal of physiology. Heart and circulatory physiology.

Population Estimation of the Effects of Cytochrome P450 2C9 and 2C19 Polymorphisms on Phenobarbital Clearance in Japanese

K. Nakagawa, Naoyuki Nakada, Shuji Goto, 2007, Therapeutic drug monitoring.

The effect of Shoseiryuto, a traditional Japanese medicine, on cytochrome P450s, N-acetyltransferase 2 and xanthine oxidase, in extensive or intermediate metabolizers of CYP2D6

K. Nakagawa, J. Saruwatari, N. Yamano, 2007, European Journal of Clinical Pharmacology.

Effects of Seijo‐bofu‐to, a Traditional Japanese Herbal Medicine Containing Furanocoumarin Derivatives, on the Drug‐Metabolizing Enzyme Activities in Healthy Male Volunteers

K. Oniki, K. Nakagawa, J. Saruwatari, 2014, Basic & clinical pharmacology & toxicology.

Younger Females Are at Greater Risk of Vasodilation-Related Adverse Symptoms Caused by Dihydropyridine Calcium Channel Blockers: Results of a Study of 11,918 Japanese Patients

K. Oniki, A. Kajiwara, K. Nakagawa, 2014, Clinical Drug Investigation.

Summer‐type hypersensitivity pneumonitis outside Japan: A case report and the state of the art

S. Han, C. Yoo, Young Whan Kim, 1997, Respirology.

Tumor Necrosis Factor Alpha and Pulmonary Function in Saskatchewan Grain Handlers

Sunita Ghosh, K. Nakagawa, H. Mcduffie, 2006, Journal of occupational and environmental medicine.

The in‐vivo effect of bakumondo‐to (TJ‐29), a traditional Japanese medicine used for treatment of chronic airway disease, on cytochrome P450 1A2, xanthine oxidase and N‐acetyltransferase 2 activity in man

T. Ishizaki, K. Nakagawa, J. Saruwatari, 2004, The Journal of pharmacy and pharmacology.

Applicability of new spin trap agent, 2-diphenylphosphinoyl-2-methyl-3,4-dihydro-2H-pyrrole N-oxide, in biological system.

Keizo Sato, K. Nakagawa, K. Sasamoto, 2008, Biochemical and biophysical research communications.

Cytochrome P450 2C19 polymorphisms and valproic acid‐induced weight gain

K. Oniki, A. Kajiwara, K. Nakagawa, 2016, Acta neurologica Scandinavica.

Possible association between moderate intellectual disability and weight gain in valproic acid–treated patients with epilepsy

K. Oniki, K. Nakagawa, J. Saruwatari, 2015, Neuropsychiatric disease and treatment.

A Possible Association of Sex Hormone-Binding Globulin with Weight Gain in the Valproic Acid-Treated Female Patients with Epilepsy

K. Oniki, A. Kajiwara, K. Nakagawa, 2014 .

Response to letter regarding article, "Effects of endothelial dysfunction on residual platelet aggregability after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease".

S. Hokimoto, K. Fujisue, K. Kaikita, 2013, Circulation. Cardiovascular interventions.

Association between paraoxonase-1 Q192R polymorphism and lung function among Saskatchewan grain handlers.

Sunita Ghosh, K. Nakagawa, H. Mcduffie, 2007, Pharmacogenomics.

Phenotype-genotype analysis of CYP1A2 in Japanese patients receiving oral theophylline therapy

K. Nakagawa, J. Saruwatari, K. Fukuda, 2005, European Journal of Clinical Pharmacology.

A novel compound heterozygote (FAP ATTR Arg104His/ATTR Val30Met) with high serum transthyretin (TTR) and retinol binding protein (RBP) levels.

H. Ideta, M. Saraiva, Y. Ando, 1999, Biochemical and biophysical research communications.

Helicobacter Pylori-seropositivity along with genetic and environmental factors predicts clinical outcome after acute coronary syndrome.

Y. Izumiya, K. Sakamoto, N. Tabata, 2016, International journal of cardiology.

Sex differences in the effect of cytochrome P450 2C19 polymorphisms on the risk of diabetic retinopathy: a retrospective longitudinal study in Japanese patients with type 2 diabetes

K. Oniki, A. Kajiwara, K. Nakagawa, 2013, Pharmacogenetics and genomics.

Effects of CYP2C19 genotypic differences in the metabolism of omeprazole and rabeprazole on intragastric pH

K. Ohashi, Kaoru Kobayashi, K. Chiba, 2001, Alimentary pharmacology & therapeutics.

Effect of sildenafil citrate (Viagra) on erectile dysfunction in a patient with familial amyloidotic polyneuropathy ATTR Val30Met.

Y. Ando, M. Suga, M. Uchino, 2000, Journal of the autonomic nervous system.

An in vitro interethnic comparison of monoamine oxidase activities between Japanese and Caucasian livers using rizatriptan, a serotonin receptor 1B/1D agonist, as a model drug.

T. Ishizaki, K. Nakagawa, K. Hara, 2003, British journal of clinical pharmacology.

Impact of CYP3A5 polymorphism on platelet reactivity at percutaneous coronary intervention and after 9 months of aspirin and clopidogrel therapy in Japanese patients with coronary artery disease

S. Hokimoto, Y. Arima, K. Kaikita, 2014, European Journal of Clinical Pharmacology.

Comparison of the kinetic disposition of and serum gastrin change by lansoprazole versus rabeprazole during an 8-day dosing scheme in relation to CYP2C19 polymorphism

T. Ishizaki, I. Ieiri, K. Nakagawa, 2001, European Journal of Clinical Pharmacology.

Amyloid formation in rat transthyretin: effect of oxidative stress.

K. Kamide, H. Kai, Masaaki Nakamura, 2002, Clinica chimica acta; international journal of clinical chemistry.

Population Estimation Regarding the Effects of Cytochrome P450 2C19 and 3A5 Polymorphisms on Zonisamide Clearance

K. Nakagawa, Atsuko Wanibuchi, Takayuki Seo, 2008, Therapeutic drug monitoring.

Aspergillus niger pneumonia with fatal pulmonary oxalosis

K. Nakagawa, Y. Nakagawa, K. Shimazu, 1999, Journal of Infection and Chemotherapy.

Ethnic differences between Japanese and Caucasians in the expression levels of mRNAs for CYP3A4, CYP3A5 and CYP3A7: lack of co-regulation of the expression of CYP3A in Japanese livers

S. Yamaori, K. Kiyotani, T. Kamataki, 2005, Xenobiotica; the fate of foreign compounds in biological systems.

Common variants of HNF1A gene are associated with diabetic retinopathy and poor glycemic control in normal-weight Japanese subjects with type 2 diabetes mellitus.

K. Oniki, K. Morita, A. Kajiwara, 2017, Journal of diabetes and its complications.

[Female sex as a risk factor for adverse drug reactions].

A. Kajiwara, K. Nakagawa, 2015, Nihon rinsho. Japanese journal of clinical medicine.

VARIANT TRANSTHYRETIN IN BLOOD CIRCULATION CAN TRANSVERSE THE BLOOD-CEREBROSPINAL BARRIER: QUALITATIVE ANALYSES OF TRANSTHYRETIN METABOLISM IN SEQUENTIAL LIVER TRANSPLANTATION1

S. Uemoto, Masaaki Nakamura, Y. Ando, 2001, Transplantation.

Presence of autoantibody against ATTR Val30Met after sequential liver transplantation.

S. Uemoto, Masaaki Nakamura, Y. Ando, 2002, Transplantation.

Update on the Genetic Polymorphisms of Drug-Metabolizing Enzymes in Antiepileptic Drug Therapy

K. Nakagawa, J. Saruwatari, T. Ishitsu, 2010, Pharmaceuticals.

Determination of the Optimal Concentration of Valproic Acid in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis

K. Oniki, K. Nakagawa, J. Saruwatari, 2015, PloS one.

Glutathione‐S‐Transferase (GST) M1 Null Genotype and Combined GSTM1 and GSTT1 Null Genotypes as a Risk Factor for Alcoholic Mild Liver Dysfunction

K. Oniki, K. Nakagawa, S. Mihara, 2007, Clinical pharmacology and therapeutics.

SCN1A IVS5N+5 polymorphism and response to sodium valproate: a multicenter study.

H. Tan, P. Kwan, L. Baum, 2012, Pharmacogenomics.

Clinical features associated with a rapid decline in renal function among Japanese patients with type 2 diabetes mellitus: microscopic hematuria coexisting with diabetic retinopathy.

K. Oniki, A. Kajiwara, K. Nakagawa, 2013, Diabetes research and clinical practice.

Helicobacter pylori-seropositivity along with pro-inflammatory interleukin-1 polymorphisms correlated with myocardial infarction ☆

Y. Izumiya, K. Sakamoto, S. Hokimoto, 2016 .

Impact of CYP2C19 polymorphisms on the efficacy of clobazam therapy.

K. Nakagawa, M. Hori, Takayuki Seo, 2008, Pharmacogenomics.

Deactivation of anti-cancer drug letrozole to a carbinol metabolite by polymorphic cytochrome P450 2A6 in human liver microsomes

T. Kamataki, K. Nakagawa, R. Kawai, 2009, Xenobiotica; the fate of foreign compounds in biological systems.

Patients with both CYP2C19 loss-of-function allele and peripheral endothelial dysfunction are significantly correlated with adverse cardiovascular events following coronary stent implantation.

Y. Izumiya, K. Sakamoto, S. Hokimoto, 2016, Journal of cardiology.

Effects of Endothelial Dysfunction on Residual Platelet Aggregability After Dual Antiplatelet Therapy With Aspirin and Clopidogrel in Patients With Stable Coronary Artery Disease

S. Hokimoto, K. Fujisue, K. Kaikita, 2013, Circulation. Cardiovascular interventions.

Therapeutic relevance of pharmacogenetic factors in cardiovascular medicine.

T. Ishizaki, K. Nakagawa, 2000, Pharmacology & therapeutics.

Association between aldehyde dehydrogenase 2 polymorphisms and the incidence of diabetic retinopathy among Japanese subjects with type 2 diabetes mellitus

K. Oniki, K. Morita, A. Kajiwara, 2013, Cardiovascular Diabetology.

The combination of mitochondrial low enzyme-activity aldehyde dehydrogenase 2 allele and superoxide dismutase 2 genotypes increases the risk of hypertension in relation to alcohol consumption

K. Oniki, A. Kajiwara, K. Nakagawa, 2013, Pharmacogenetics and genomics.

Impact of CYP2C19 polymorphism on clinical outcome following coronary stenting is more important in non-diabetic than diabetic patients.

S. Hokimoto, Y. Arima, K. Kaikita, 2014, Thrombosis research.

Two Novel CYP2D6*10 Haplotypes As Possible Causes of a Poor Metabolic Phenotype in Japanese

Hiroshi Yamazaki, Masayuki Matsunaga, H. Yamazaki, 2009, Drug Metabolism and Disposition.

Effects of Polymorphic Variations in Tumor Necrosis Factor Alpha and Occupational Exposure to Grain Dust on Longitudinal Decline in Pulmonary Function

K. Nakagawa, N. Koehncke, H. Mcduffie, 2009, Journal of agromedicine.

Association between cytochrome P450 3A5 polymorphism and the lung function in Saskatchewan grain workers

Sunita Ghosh, K. Nakagawa, H. Mcduffie, 2008, Pharmacogenetics and genomics.

Gender differences in the incidence and progression of diabetic retinopathy among Japanese patients with type 2 diabetes mellitus: a clinic-based retrospective longitudinal study.

K. Oniki, A. Kajiwara, K. Nakagawa, 2014, Diabetes research and clinical practice.

Combined glutathione S-transferase T1 and M1 positive genotypes afford protection against type 2 diabetes in Japanese.

K. Oniki, K. Nakagawa, S. Mihara, 2007, Pharmacogenomics.

Higher Risk of Sulfonylurea-associated Hypoglycemic Symptoms in Women with Type 2 Diabetes Mellitus

K. Oniki, K. Morita, A. Kajiwara, 2015, Clinical Drug Investigation.

Variant Aldehyde Dehydrogenase 2 (ALDH2*2) Is a Risk Factor for Coronary Spasm and ST‐Segment Elevation Myocardial Infarction

S. Hokimoto, H. Ogawa, K. Nakagawa, 2016, Journal of the American Heart Association.

The clinical impact of cytochrome P450 polymorphisms on anti-epileptic drug therapy

K. Nakagawa, J. Saruwatari, S. Kaneko, 2010 .

ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients.

K. Nakagawa, Naoyuki Nakada, Takayuki Seo, 2006, Pharmacogenomics.

Association between SCN1A polymorphism and carbamazepine-resistant epilepsy.

K. Nakagawa, Tomohide Abe, M. Hori, 2008, British journal of clinical pharmacology.

A herbal‐drug interaction study of keishi‐bukuryo‐gan, a traditional herbal preparation used for menopausal symptoms, in healthy female volunteers

K. Nakagawa, J. Saruwatari, Kousuke Yoshida, 2012, The Journal of pharmacy and pharmacology.

Effects of CYP2C19 and P450 Oxidoreductase Polymorphisms on the Population Pharmacokinetics of Clobazam and N-Desmethylclobazam in Japanese Patients With Epilepsy

K. Nakagawa, J. Saruwatari, S. Kaneko, 2014, Therapeutic drug monitoring.

A Novel Tool for Detecting Amyloid Deposits in Systemic Amyloidosis In Vitro and In Vivo

K. Doh-ura, Masaaki Nakamura, Y. Ando, 2003, Laboratory Investigation.

Possible associations between antioxidant enzyme polymorphisms and metabolic abnormalities in patients with schizophrenia

Norio Sugawara, K. Oniki, A. Kajiwara, 2013, Neuropsychiatric disease and treatment.

Prescription of triazolam for the elderly in Japan: A sub-analysis of the drug event monitoring project by the Japan Pharmaceutical Association

K. Oniki, K. Morita, A. Kajiwara, 2016 .

The Effect of Yokukansan, a Traditional Herbal Preparation Used for the Behavioral and Psychological Symptoms of Dementia, on the Drug-Metabolizing Enzyme Activities in Healthy Male Volunteers.

K. Oniki, K. Nakagawa, J. Saruwatari, 2016, Biological & pharmaceutical bulletin.

Helicobacter pylori Seropositivity in Patients with Interleukin-1 Polymorphisms Is Significantly Associated with ST-Segment Elevation Myocardial Infarction

Y. Izumiya, K. Sakamoto, S. Hokimoto, 2016, PloS one.

Association between glutathione S-transferase A1, M1 and T1 polymorphisms and hypertension

K. Oniki, K. Nakagawa, S. Mihara, 2008, Pharmacogenetics and genomics.

Pregnane X receptor and hepatocyte nuclear factor 4&agr; polymorphisms are cooperatively associated with carbamazepine autoinduction

K. Oniki, K. Nakagawa, J. Saruwatari, 2014, Pharmacogenetics and genomics.

Superoxide dismutase 2 Val16Ala polymorphism is a risk factor for the valproic acid-related elevation of serum aminotransferases

K. Oniki, K. Nakagawa, J. Saruwatari, 2012, Epilepsy Research.

Superoxide scavenging activity of erythromycin-iron complex.

H. Maeda, T. Akaike, M. Suga, 1997, Biochemical and biophysical research communications.

Associations between the common HNF1A gene variant p.I27L (rs1169288) and risk of type 2 diabetes mellitus are influenced by weight.

K. Oniki, K. Morita, A. Kajiwara, 2015, Diabetes & metabolism.

ABCC2 haplotype is not associated with drug‐resistant epilepsy

T. Shuto, K. Oniki, K. Nakagawa, 2008, The Journal of pharmacy and pharmacology.

Absence of gargling affects topical adverse symptoms caused by inhaled corticosteroids in females

K. Oniki, K. Morita, A. Kajiwara, 2014, The Journal of asthma : official journal of the Association for the Care of Asthma.

CYP3A5 Contributes significantly to CYP3A-mediated drug oxidations in liver microsomes from Japanese subjects.

H. Yamazaki, K. Kiyotani, T. Kamataki, 2004, Drug metabolism and pharmacokinetics.

Association between cytochrome P450 3A5 polymorphism and the lung function in Saskatchewan grain workers

Sunita Ghosh, K. Nakagawa, P. Pahwa, 2008, Pharmacogenetics and genomics.

Interactive effect of paraoxonase-1 Q192R polymorphism and smoking history on the lung function decline in grain workers.

Sunita Ghosh, K. Nakagawa, P. Pahwa, 2008, Annals of epidemiology.

Helicobacter pylori-seropositivity along with pro-inflammatory interleukin-1 polymorphisms correlated with myocardial infarction ☆

K. Sakamoto, S. Hokimoto, D. Sueta, 2016 .

Association of CYP2C19 variants and epoxyeicosatrienoic acids on patients with microvascular angina.

S. Hokimoto, D. Sueta, Y. Arima, 2016, American journal of physiology. Heart and circulatory physiology.

Sex differences in the impact of CYP2C19 polymorphisms and low-grade inflammation on coronary microvascular disorder.

K. Sakamoto, S. Hokimoto, D. Sueta, 2016, American journal of physiology. Heart and circulatory physiology.

Determination of cut-off levels for on-clopidogrel platelet aggregation based on functional CYP2C19 gene variants in patients undergoing elective percutaneous coronary intervention.

S. Hokimoto, Koji Sato, S. Tayama, 2011, Thrombosis research.

Effect of CYP3A5*3 on carbamazepine pharmacokinetics in Japanese patients with epilepsy

K. Nakagawa, Naoyuki Nakada, Takayuki Seo, 2006, Clinical pharmacology and therapeutics.

The Effect of Yokukansan, a Traditional Herbal Preparation Used for the Behavioral and Psychological Symptoms of Dementia, on the Drug-Metabolizing Enzyme Activities in Healthy Male Volunteers.

N. Yasui-Furukori, K. Oniki, K. Nakagawa, 2016, Biological & pharmaceutical bulletin.